This cohort study of 1,769 hip fracture patients (age ≥60) at a single UK centre (March 2020–December 2024) examined whether the *cause* of surgical delay (<36 h vs ≥36 h) — administrative (theatre unavailability) vs medical (optimisation) — independently predicted 30-day and 1-year mortality.
Delays caused solely by theatre unavailability did not increase 30-day (OR 0.784, p=0.398) or 1-year mortality (OR 1.123, p=0.474), whereas delays for medical optimisation were associated with markedly higher 30-day (OR 3.573, p<0.001) and 1-year mortality (OR 2.144, p=0.005).
Single-centre UK study limits generalisability; the observational design cannot exclude residual confounding by unmeasured illness severity among medically delayed patients; data span included the COVID-19 pandemic period, which may have distorted theatre capacity and patient acuity patterns.
For hip fracture patients delayed due to medical illness rather than theatre access, clinicians should prioritise aggressive pre-operative optimisation and orthogeriatric input — not just faster surgical throughput — as this group carries the highest mortality risk. Administrative delays alone should not be conflated with clinically harmful delays when auditing performance.
Explore related topics